[HTML][HTML] The role of focal therapy in the management of localised prostate cancer: a systematic review
Context The incidence of localised prostate cancer is increasing worldwide. In light of recent
evidence, current, radical, whole-gland treatments for organ-confined disease have being …
evidence, current, radical, whole-gland treatments for organ-confined disease have being …
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology
JP Droz, M Aapro, L Balducci, H Boyle… - The lancet …, 2014 - thelancet.com
Summary In 2010, the International Society of Geriatric Oncology (SIOG) developed
treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013 …
treatment guidelines for men with prostate cancer who are older than 70 years old. In 2013 …
[HTML][HTML] Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting
IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge… - European urology, 2015 - Elsevier
Background Focal therapy as a treatment option for localized prostate cancer (PCa) is an
increasingly popular and rapidly evolving field. Objective To gather expert opinion on patient …
increasingly popular and rapidly evolving field. Objective To gather expert opinion on patient …
Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging–guided biopsies versus a systematic 10-core …
T Hambrock, C Hoeks, C Hulsbergen-Van De Kaa… - European urology, 2012 - Elsevier
BACKGROUND: Accurate pretreatment assessment of prostate cancer (PCa)
aggressiveness is important in decision making. Gleason grade is a critical predictor of the …
aggressiveness is important in decision making. Gleason grade is a critical predictor of the …
Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018
HG van der Poel, RCN van den Bergh, E Briers… - European urology, 2018 - Elsevier
Radical treatment of localised prostate cancer is recognised to be an unnecessary
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …
Characterizing clinically significant prostate cancer using template prostate map** biopsy
Purpose: Definitions of prostate cancer risk are limited since accurate attribution of the
cancer grade and burden is not possible due to the random and systematic errors …
cancer grade and burden is not possible due to the random and systematic errors …
Focal therapy in prostate cancer: international multidisciplinary consensus on trial design
Background Focal therapy has been introduced for the treatment of localised prostate
cancer (PCa). To provide the necessary data for consistent assessment, all focal therapy …
cancer (PCa). To provide the necessary data for consistent assessment, all focal therapy …
Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program
Purpose To assess the predictive ability of prostate-specific antigen (PSA) velocity (PSAV)
and doubling time (PSADT) for biopsy progression and adverse pathology at prostatectomy …
and doubling time (PSADT) for biopsy progression and adverse pathology at prostatectomy …
[HTML][HTML] Prototypical few-shot segmentation for cross-institution male pelvic structures with spatial registration
The prowess that makes few-shot learning desirable in medical image analysis is the
efficient use of the support image data, which are labelled to classify or segment new …
efficient use of the support image data, which are labelled to classify or segment new …
Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project
Background: Whole-gland extirpation or irradiation is considered the gold standard for
curative oncological treatment for localized prostate cancer, but is often associated with …
curative oncological treatment for localized prostate cancer, but is often associated with …